AT382381B - Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate - Google Patents
Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivateInfo
- Publication number
- AT382381B AT382381B AT312184A AT312184A AT382381B AT 382381 B AT382381 B AT 382381B AT 312184 A AT312184 A AT 312184A AT 312184 A AT312184 A AT 312184A AT 382381 B AT382381 B AT 382381B
- Authority
- AT
- Austria
- Prior art keywords
- new interface
- producing new
- carbohydrate derivatives
- interface characteristic
- characteristic carbohydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
- C08B31/125—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch having a substituent containing at least one nitrogen atom, e.g. cationic starch
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT312184A AT382381B (de) | 1984-10-02 | 1984-10-02 | Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate |
EP19850904581 EP0197053A1 (de) | 1984-10-02 | 1985-10-01 | Grenzflächenaktive kohlenhydrat-derivate und verfahren zu deren herstellung |
PCT/AT1985/000036 WO1986002076A1 (en) | 1984-10-02 | 1985-10-01 | Surfactant carbon hydrate derivatives and process for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT312184A AT382381B (de) | 1984-10-02 | 1984-10-02 | Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA312184A ATA312184A (de) | 1986-07-15 |
AT382381B true AT382381B (de) | 1987-02-25 |
Family
ID=3545630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT312184A AT382381B (de) | 1984-10-02 | 1984-10-02 | Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0197053A1 (de) |
AT (1) | AT382381B (de) |
WO (1) | WO1986002076A1 (de) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7390788B2 (en) | 2005-06-23 | 2008-06-24 | Pert Candace B | Peptide pharmaceutical compositions |
EP2158920A1 (de) | 2006-06-23 | 2010-03-03 | Aegis Therapeutics LLC | Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren |
WO2010075465A1 (en) | 2008-12-22 | 2010-07-01 | Aegis Therapeutics, Llc | Compositions for drug administration |
WO2011036521A2 (en) | 2009-09-25 | 2011-03-31 | Dr. Reddy's Laboratories Limited | Formulations comprising triptan compounds |
EP2457580A1 (de) | 2004-08-25 | 2012-05-30 | The UAB Research Foundation | Absorptionsverbesserer zur Arzneimittelverabreichung |
WO2012158962A2 (en) | 2011-05-18 | 2012-11-22 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
WO2015184177A1 (en) | 2014-05-28 | 2015-12-03 | Mederis Diabetes, Llc | Improved peptide pharmaceuticals for insulin resistance |
WO2018065634A1 (en) | 2016-10-07 | 2018-04-12 | Cyprumed Gmbh | Pharmaceutical compositions for the nasal delivery of peptide or protein drugs |
EP3434696A1 (de) | 2012-11-20 | 2019-01-30 | Mederis Diabetes, LLC | Verbesserte peptidarzneimittel für insulinresistenz |
EP3444281A1 (de) | 2012-11-20 | 2019-02-20 | Eumederis Pharmaceuticals, Inc. | Verbesserte peptidarzneimittel |
WO2019193204A1 (en) | 2018-04-06 | 2019-10-10 | Cyprumed Gmbh | Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins |
WO2020049523A1 (en) | 2018-09-07 | 2020-03-12 | Upsher-Smith Laboratories, Llc | Methods of treating migraine |
WO2022049310A1 (en) | 2020-09-07 | 2022-03-10 | Cyprumed Gmbh | Improved pharmaceutical formulations of glp-1 receptor agonists |
US11541028B2 (en) | 2018-01-03 | 2023-01-03 | Altimmune Inc. | Peptide pharmaceuticals for treatment of NASH and other disorders |
WO2023166179A1 (en) | 2022-03-03 | 2023-09-07 | Cyprumed Gmbh | Improved oral pharmaceutical formulations of therapeutic peptides and proteins |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4413686C2 (de) * | 1994-04-20 | 1996-10-24 | Henkel Kgaa | Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung |
US5627273A (en) * | 1995-01-31 | 1997-05-06 | National Starch And Chemical Investment Holding Corporation | Method for preparing hydrophobically-terminated polysaccharide polymers and detergent compositions comprising the polysaccharide polymers |
WO2006040335A1 (en) * | 2004-10-15 | 2006-04-20 | Danisco A/S | A derivatized highly branched polysaccharide and a mix for production of polyurethane thereof |
AU2005293571A1 (en) * | 2004-10-15 | 2006-04-20 | Danisco A/S | A foamed isocyanate-based polymer, a mix and process for production thereof |
US7465757B2 (en) | 2004-10-15 | 2008-12-16 | Danisco A/S | Foamed isocyanate-based polymer, a mix and process for production thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0096292A1 (de) * | 1982-05-29 | 1983-12-21 | BEHRINGWERKE Aktiengesellschaft | Beta-D-Galactosederivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR903547A (fr) * | 1943-04-08 | 1945-10-08 | Ste Ind Chim Bale | Nouveaux composés amidiques |
AT360046B (de) * | 1979-04-12 | 1980-12-10 | Oesterr Zuckerfab Evidenz | Verfahren zur herstellung von neuen kohlen- hydrat-derivaten |
AT369383B (de) * | 1981-06-12 | 1982-12-27 | Oesterr Zuckerfab Evidenz | Verfahren zur herstellung von beta-amidoethyl -ether-derivaten |
-
1984
- 1984-10-02 AT AT312184A patent/AT382381B/de not_active IP Right Cessation
-
1985
- 1985-10-01 WO PCT/AT1985/000036 patent/WO1986002076A1/de unknown
- 1985-10-01 EP EP19850904581 patent/EP0197053A1/de not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0096292A1 (de) * | 1982-05-29 | 1983-12-21 | BEHRINGWERKE Aktiengesellschaft | Beta-D-Galactosederivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2457580A1 (de) | 2004-08-25 | 2012-05-30 | The UAB Research Foundation | Absorptionsverbesserer zur Arzneimittelverabreichung |
US7390788B2 (en) | 2005-06-23 | 2008-06-24 | Pert Candace B | Peptide pharmaceutical compositions |
EP2158920A1 (de) | 2006-06-23 | 2010-03-03 | Aegis Therapeutics LLC | Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren |
EP2158898A1 (de) | 2006-06-23 | 2010-03-03 | Aegis Therapeutics LLC | Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren |
EP2505189A1 (de) | 2006-06-23 | 2012-10-03 | Aegis Therapeutics, LLC | Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren |
WO2010075465A1 (en) | 2008-12-22 | 2010-07-01 | Aegis Therapeutics, Llc | Compositions for drug administration |
WO2011036521A2 (en) | 2009-09-25 | 2011-03-31 | Dr. Reddy's Laboratories Limited | Formulations comprising triptan compounds |
WO2012158962A2 (en) | 2011-05-18 | 2012-11-22 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
EP4286400A2 (de) | 2011-05-18 | 2023-12-06 | Eumederis Pharmaceuticals, Inc. | Verbesserte peptidarzneimittel |
EP3566711A1 (de) | 2011-05-18 | 2019-11-13 | Eumederis Pharmaceuticals, Inc. | Verbesserte peptidarzneimittel |
EP3434696A1 (de) | 2012-11-20 | 2019-01-30 | Mederis Diabetes, LLC | Verbesserte peptidarzneimittel für insulinresistenz |
EP3444281A1 (de) | 2012-11-20 | 2019-02-20 | Eumederis Pharmaceuticals, Inc. | Verbesserte peptidarzneimittel |
EP3653649A1 (de) | 2012-11-20 | 2020-05-20 | Mederis Diabetes, LLC | Verbesserte peptidarzneimittel für insulinresistenz |
EP4047023A1 (de) | 2012-11-20 | 2022-08-24 | Eumederis Pharmaceuticals, Inc. | Verbesserte peptidarzneimittel |
WO2015184177A1 (en) | 2014-05-28 | 2015-12-03 | Mederis Diabetes, Llc | Improved peptide pharmaceuticals for insulin resistance |
WO2018065634A1 (en) | 2016-10-07 | 2018-04-12 | Cyprumed Gmbh | Pharmaceutical compositions for the nasal delivery of peptide or protein drugs |
US11541028B2 (en) | 2018-01-03 | 2023-01-03 | Altimmune Inc. | Peptide pharmaceuticals for treatment of NASH and other disorders |
WO2019193204A1 (en) | 2018-04-06 | 2019-10-10 | Cyprumed Gmbh | Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins |
WO2020049523A1 (en) | 2018-09-07 | 2020-03-12 | Upsher-Smith Laboratories, Llc | Methods of treating migraine |
WO2022049310A1 (en) | 2020-09-07 | 2022-03-10 | Cyprumed Gmbh | Improved pharmaceutical formulations of glp-1 receptor agonists |
WO2023166179A1 (en) | 2022-03-03 | 2023-09-07 | Cyprumed Gmbh | Improved oral pharmaceutical formulations of therapeutic peptides and proteins |
Also Published As
Publication number | Publication date |
---|---|
EP0197053A1 (de) | 1986-10-15 |
ATA312184A (de) | 1986-07-15 |
WO1986002076A1 (en) | 1986-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT373599B (de) | Verfahren zur herstellung neuer rifamycinderivate | |
AT382381B (de) | Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate | |
AT389302B (de) | Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate | |
ATA376184A (de) | Verfahren zur herstellung neuer polysubstituierter naphthalinderivate | |
ATA364384A (de) | Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate | |
AT386208B (de) | Verfahren zur herstellung neuer carbapenemzwischenverbindungen | |
ATA165685A (de) | Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate | |
ATA337185A (de) | Verfahren zur herstellung neuer flavolignanderivate | |
ATA233086A (de) | Verfahren zur herstellung neuer peptidantibiotika | |
ATA124285A (de) | Verfahren zur herstellung neuer iminothiazolidinderivate | |
ATA444982A (de) | Verfahren zur herstellung neuer bisindolalkaloidderivate | |
ATA335685A (de) | Verfahren zur herstellung neuer thienopyridinderivate | |
ATA371584A (de) | Verfahren zur herstellung neuer cephalosporanderivate | |
ATA310385A (de) | Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate | |
ATA172385A (de) | Verfahren zur herstellung neuer naphthoxazine | |
ATA305785A (de) | Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate | |
AT387015B (de) | Verfahren zur herstellung neuer acylaminophenolderivate | |
AT376217B (de) | Verfahren zur herstellung neuer 3-chlorchinolinderivate | |
ATA260285A (de) | Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate | |
AT387576B (de) | Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate | |
AT381097B (de) | Verfahren zur herstellung neuer thiazolintriazinderivate | |
ATA143885A (de) | Verfahren zur herstellung neuer chinolinderivate | |
ATA86285A (de) | Verfahren zur herstellung neuer thiazolderivate | |
AT388557B (de) | Verfahren zur herstellung neuer bornanderivate | |
AT383118B (de) | Verfahren zur herstellung neuer azetidinonderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee | ||
ELJ | Ceased due to non-payment of the annual fee |